A Multicountry Analysis of Prevalence and Mortality among Neonates and Children with Bladder Exstrophy

Abstract

Objective Bladder exstrophy (BE) is a rare but severe birth defect affecting the lower abdominal wall and genitourinary system. The objective of the study is to examine the total prevalence, trends in prevalence, and age-specific mortality among individuals with BE.

Study Design We conducted a retrospective cohort study. Data were analyzed from 20 birth defects surveillance programs, members of the International Clearinghouse for Birth Defects Surveillance and Research in 16 countries. Live births, stillbirths, and elective terminations of pregnancy for fetal anomaly (ETOPFA) diagnosed with BE from 1974 to 2014. Pooled and program-specific prevalence of BE per 100,000 total births was calculated. The 95% confidence intervals (CI) for prevalence were estimated using Poisson approximation of binomial distribution. Time trends in prevalence of BE from 2000 to 2014 were examined using Poisson regression. Proportion of deaths among BE cases was calculated on the day of birth, day 2 to 6, day 7 to 27, day 28 to 364, 1 to 4 years, and ≥5 years. Mortality analysis was stratified by isolated, multiple, and syndromic case status.

Results The pooled total prevalence of BE was 2.58 per 100,000 total births (95% CI = 2.40, 2.78) for study years 1974 to 2014. Prevalence varied over time with a decreasing trend from 2000 to 2014. The first-week mortality proportion was 3.5, 17.3, and 14.6% among isolated, multiple, and syndromic BE cases, respectively. The majority of first-week mortality occurred on the first day of life among isolated, multiple, and syndromic BE cases. The proportion of first-week deaths was higher among cases reported from programs in Latin America where ETOPFA services were not available.

Conclusion Prevalence of BE varied by program and showed a decreasing trend from 2000 to –2014. Mortality is a concern among multiple and syndromic cases, and a high proportion of deaths among cases occurred during the first week of life.

Key Points

• Total prevalence of BE was 2.58 per 100,000 births.

• Prevalence decreased from 2000 to 2014.

• The first-week mortality was 9.3%.

Keywords

birth defects - bladder exstrophy - epidemiology - mortality - prevalence - surveillance

Note

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. This analysis has been replicated by Manasvi Sundar (Emory University).

^* These authors contributed equally to this article.

Publikationsverlauf

Eingereicht: 20. Juli 2021

Angenommen: 18. Februar 2022

Artikel online veröffentlicht:
29. Mai 2022

• References

• 1 Uludag S, Guralp O, Akbas M, Aydin Y, Sen C, Uludag S. Bladder exstrophy. Fetal Pediatr Pathol 2012; 31 (04) 225-229
• 2 Ludwig M, Ching B, Reutter H, Boyadjiev SA. Bladder exstrophy-epispadias complex. Birth Defects Res A Clin Mol Teratol 2009; 85 (06) 509-522
• 3 Barth RA, Filly RA, Sondheimer FK. Prenatal sonographic findings in bladder exstrophy. J Ultrasound Med 1990; 9 (06) 359-361
• 4 Anand S, Lotfollahzadeh S. Treasure Island (FL): Bladder Exstrophy StatPearls;. 2020
• 5 Kulkarni B, Chaudhari N. Embryogenesis of bladder exstrophy: a new hypothesis. J Indian Assoc Pediatr Surg 2008; 13 (02) 57-60
• 6 K V SK, Mammen A, Varma KK. . Pathogenesis of bladder exstrophy: a new hypothesis. J Pediatr Urol 2015; 6: 314-318
• 7 Cacciari A, Pilu GL, Mordenti M, Ceccarelli PL, Ruggeri G. Prenatal diagnosis of bladder exstrophy: what counseling?. J Urol 1999; 161 (01) 259-261 , discussion 262
• 8 Macfarlane MT, Lattimer JK, Hensle TW. Improved life expectancy for children with exstrophy of the bladder. JAMA 1979; 242 (05) 442-444
• 9 Dickson AP. The management of bladder exstrophy: the Manchester experience. J Pediatr Surg 2014; 49 (02) 244-250
• 10 Stuhldreher PP, Gearhart JP. Re: Clinical outcome of cloacal exstrophy, current status, and a change in surgical management. Eur Urol 2015; 68 (02) 337
• 11 Arab HO, Helmy TE, Abdelhalim A, Soltan M, Dawaba ME, Hafez AT. Complete primary repair of bladder exstrophy: critical analysis of the long-term outcome. Urology 2018; 117: 131-136
• 12 Inouye BM, Massanyi EZ, Di Carlo H, Shah BB, Gearhart JP. Modern management of bladder exstrophy repair. Curr Urol Rep 2013; 14 (04) 359-365
• 13 Ellison JS, Shnorhavorian M, Willihnganz-Lawson K, Grady R, Merguerian PA. A critical appraisal of continence in bladder exstrophy: long-term outcomes of the complete primary repair. J Pediatr Urol 2016; 12 (04) 205.e1-205.e7
• 14 Wood D, Baird A, Carmignani L. et al. Lifelong congenital urology: the challenges for patients and surgeons. Eur Urol 2019; 75 (06) 1001-1007
• 15 Nelson CP, Dunn RL, Wei JT. Contemporary epidemiology of bladder exstrophy in the United States. J Urol 2005; 173 (05) 1728-1731
• 16 Siffel C, Correa A, Amar E. et al. Bladder exstrophy: an epidemiologic study from the International Clearinghouse for Birth Defects Surveillance and Research, and an overview of the literature. Am J Med Genet C Semin Med Genet 2011; 157C [phone]
• 17 International Clearinghouse for Birth Defects Monitoring Systems (ICBDMS). Epidemiology of bladder exstrophy and epispadias: a communication from the International Clearinghouse for Birth Defects Monitoring Systems. Teratology 1987; 36 (02) 221-227
• 18 Yang P, Khoury MJ, Stewart WF. et al. Comparative epidemiology of selected midline congenital abnormalities. Genet Epidemiol 1994; 11 (02) 141-154
• 19 Caton AR, Bloom A, Druschel CM, Kirby RS. Epidemiology of bladder and cloacal exstrophies in New York State, 1983-1999. Birth Defects Res A Clin Mol Teratol 2007; 79 (11) 781-787
• 20 Cervellione RM, Mantovani A, Gearhart J. et al. Prospective study on the incidence of bladder/cloacal exstrophy and epispadias in Europe. J Pediatr Urol 2015; 11 (06) 337.e1-337.e6
• 21 Kockum CC, Hansson E, Stenberg A, Svensson J, Malmfors G. Bladder exstrophy in Sweden–a long-term follow-up study. Eur J Pediatr Surg 1996; 6 (04) 208-211
• 22 Heinke D, Nestoridi E, Hernandez-Diaz S. et al; National Birth Defects Prevention Study. Risk of stillbirth for fetuses with specific birth defects. Obstet Gynecol 2020; 135 (01) 133-140
• 23 Forrester MB, Merz RD. First-year mortality rates for selected birth defects, Hawaii, 1986-1999. Am J Med Genet A 2003; 119A [phone]
• 24 EUROCAT- European Surviellance of Congenital Anomalies. Prevalence charts and tables: Bladder Exstrophy and/or epispadia 2021. Accessed March 20, 2022 at: https://eu-rd-platform.jrc.ec.europa.eu/eurocat/eurocat-data/prevalence_en
• 25 Martínez-Frías ML, Bermejo E, Rodríguez-Pinilla E, Frías JL. Exstrophy of the cloaca and exstrophy of the bladder: two different expressions of a primary developmental field defect. Am J Med Genet 2001; 99 (04) 261-269
• 26 Rickham PP. The incidence and treatment of ectopia vesicae. Proc R Soc Med 1961; (54) 389-392
• 27 Bird TM, Hobbs CA, Cleves MA, Tilford JM, Robbins JM. National rates of birth defects among hospitalized newborns. Birth Defects Res A Clin Mol Teratol 2006; 76 (11) 762-769
• 28 Reinfeldt Engberg G, Mantel Ä, Fossum M, Nordenskjöld A. Maternal and fetal risk factors for bladder exstrophy: a nationwide Swedish case-control study. J Pediatr Urol 2016; 12 (05) 304.e1-304.e7